Atacicept Completed Phase 2 / 3 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT01972568Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus